Evidence map›Paper›PMID 39677701›Full record

ArticlebioRxiv : the preprint server for biology2025

Hyperactive neuronal networks enhance tau spread in an Alzheimer's disease mouse model.

Aaron J Barbour, Keegan Hoag, Eli J Cornblath, Abigail Chavez, Alfredo Lucas, Xiaofan Li, Sydney Zebrowitz, Chloe Hassman, Omar Vazquez, Sharon X Xie and 5 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Aaron J BarbourDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.
Keegan HoagDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.
Eli J CornblathDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.ORCID 0000-0002-2619-8778
Abigail ChavezDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.
Alfredo LucasDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.
Xiaofan LiDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.
Sydney ZebrowitzDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.
Chloe HassmanDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.
Omar VazquezDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.
Sharon X XieDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.
Edward B LeeTranslational Neuropathology Research Laboratory, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.ORCID 0000-0002-4589-1180
Kathryn A DavisDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.ORCID 0000-0002-7020-6480
Virginia M Y LeeDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.
Delia M TalosDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.
Frances E JensenDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.

Funding

Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Corey T McMillan · 2021 to 2026
$24.8M
Project IV: In Vivo Dissection of Genetic Modifiers on Different Stages of SynucleinopathyP01AG084497 · NIA · UNIVERSITY OF PENNSYLVANIA · PI ALICE S CHEN-PLOTKIN · 2024 to 2026
$15.2M
Training in Alzheimer’s and Age-Related Neurodegenerative DiseasesT32AG000255 · NIA · UNIVERSITY OF PENNSYLVANIA · PI ALICE S CHEN-PLOTKIN, VIRGINIA M LEE · 1997 to 2026
$12.5M
The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/PennP50HD105354 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI ERIC D MARSH, ROBERT Thomas SCHULTZ · 2021 to 2026
$9.2M
Spreading Tau Pathology in Non-Amnestic Alzheimer's DiseaseR01AG054519 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jeffrey S Phillips · 2018 to 2026
$7.4M
The Intellectual and Developmental Disabilities Research Center at CHOP/PennU54HD086984 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI ROBINSON, MICHAEL BYRNE, SCHULTZ, ROBERT THOMAS · 2016 to 2020
$6.3M
Seizure-induced enhancement of synaptic signaling regulating tau transmissibility in Alzheimer's DiseaseR01AG077692 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Frances E Jensen, Delia Talos · 2022 to 2026
$3.5M
Tracking the evolution of synaptic dysplasticity after early life seizuresR37NS115439 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Frances E Jensen · 2020 to 2026
$3.4M
The role of oxidative stress and inflammation in epileptogenesisR01NS101156 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI TALOS, DELIA · 2018 to 2022
$1.7M
Advancing the Conversations Helpful for Awareness of Illness Trajectory (CHAT) InterventionR21AG077092 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI GOYAL, PARAG, SHEN, MEGAN JOHNSON · 2023 to 2024
$486k
NIA NIH HHS P01 AG084497NIA NIH HHS P30 AG072979NIA NIH HHS R01 AG054519NIA NIH HHS R01 AG077692NIA NIH HHS R21 AG077092NIA NIH HHS T32 AG000255NICHD NIH HHS P50 HD105354NICHD NIH HHS U54 HD086984NINDS NIH HHS R01 NS101156NINDS NIH HHS R37 NS115439
6 · The paper itself

Abstract

Pathological tau spreads via neuronal connections in Alzheimer's disease (AD). Given the high incidence and deleterious consequences of epileptiform activity in AD, we hypothesized that neuronal hyperactivity and seizures exacerbate tau spread. To examine the impacts of brain-wide network and population hyperactivity on tau spread, we created a novel mouse model involving the cross of targeted recombination in active populations (TRAP) and the 5 times familial AD mice (5X-TRAP) that allows for the permanent labelling of seizure-activated neurons. To explore the effects of seizures on tau spread, we injected these mice with human AD brain-derived tau to induce pathological tau spread, and induced seizures with pentylenetetrazol (PTZ) kindling. Brain mapping revealed that seizures increased tau spread in 5X-TRAP mice, which correlated extensively with memory deficits in PTZ kindled 5X-TRAP mice. Using computational models, we found data supportive of increased anterograde tau spread in 5X-TRAP mice and that regional neuronal activity levels were predictive of tau pathology. On a cellular level, we found that hyperactive neurons drive elevated tau propagation in 5X-TRAP mice. We also found corroborating evidence of increased tau spread in AD patients with a seizure history compared to those without. Our study identifies neuronal hyperactivity and seizures as key, targetable factors underlying AD progression.

Identifiers

PMID39677701
PMCPMC11642807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.